Bionxt Solutions Inc (BNXTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,876 | -5,721 | -9,520 | -16,466 | -12,608 |
| Depreciation Amortization | 67 | 145 | 166 | 657 | 669 |
| Income taxes - deferred | -66 | N/A | -302 | -88 | -267 |
| Accounts receivable | 162 | 127 | 54 | -171 | -131 |
| Accounts payable and accrued liabilities | 477 | 98 | -563 | 364 | 161 |
| Other Working Capital | 575 | 243 | -430 | -334 | 20 |
| Other Operating Activity | 447 | 1,280 | 5,804 | 6,341 | 4,539 |
| Operating Cash Flow | $-2,214 | $-3,828 | $-4,792 | $-9,699 | $-7,618 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 41 | 75 | -3 | -361 | -117 |
| Net Acquisitions | N/A | N/A | N/A | -3,874 | N/A |
| Investing Cash Flow | $41 | $75 | $-3 | $-4,235 | $-117 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,540 | N/A | 1,987 | 1,834 | 3,456 |
| Debt Repayment | -754 | -156 | -2,646 | -232 | -199 |
| Common Stock Issued | 1,351 | 4,437 | 4,967 | 11,926 | 6,289 |
| Other Financing Activity | -206 | -359 | -444 | -578 | -102 |
| Financing Cash Flow | $1,930 | $3,921 | $3,864 | $12,950 | $9,444 |
| Exchange Rate Effect | 1 | 1 | -4 | 0 | 0 |
| Beginning Cash Position | 265 | 101 | 1,040 | 2,063 | 220 |
| End Cash Position | 24 | 269 | 105 | 1,079 | 1,930 |
| Net Cash Flow | $-242 | $169 | $-935 | $-984 | $1,709 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,214 | -3,828 | -4,792 | -9,699 | -7,618 |
| Capital Expenditure | N/A | -149 | -3 | -361 | -117 |
| Free Cash Flow | -2,214 | -3,977 | -4,795 | -10,059 | -7,735 |